Medicare Enrolled
Dr. Mukarram Baig, M.D.
Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baig from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baig?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baig
Dr. Mukarram Baig is a cardiovascular disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Baig performed 5,995 Medicare services across 3,771 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baig received a total of $5,399 from 42 pharmaceutical and/or device companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baig is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in TX
$5,399 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,995
Medicare services
Top 11% in TX for cardiovascular disease
3,771
Unique beneficiaries
$171
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~300 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
905 | $10 | $80 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
896 | $43 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
688 | $66 | $115 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
441 | $30 | $150 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
440 | $21 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
343 | $88 | $145 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
272 | $65 | $375 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
260 | $150 | $1,005 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
230 | $57 | $350 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 227 | $638 | $814 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
222 | $1,967 | $4,200 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
218 | $4 | $15 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
115 | $17 | $81 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
107 | $96 | $425 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
82 | $149 | $390 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
71 | $24 | $125 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
71 | $18 | $125 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
43 | $3,579 | $9,000 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $104 | $190 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
33 | $135 | $400 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
32 | $7 | $40 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $65 | $245 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
30 | $144 | $450 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
29 | $10 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $134 | $250 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
25 | $20 | $175 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
25 | $190 | $694 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $97 | $300 |
| Cardiac catheterization | 17 | $212 | $3,856 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
15 | $55 | $400 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
15 | $100 | $180 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
12 | $897 | $3,500 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
11 | $430 | $3,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
24.8% medium
67.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,399
Total received (2018-2024)
Avg $771/year across 7 years
Top 47% in TX for cardiovascular disease
42
Companies
263
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,399 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$925
2023
$1,129
2022
$961
2021
$226
2020
$169
2019
$628
2018
$1,361
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$784
Janssen Pharmaceuticals, Inc
$657
Amgen Inc.
$409
Novartis Pharmaceuticals Corporation
$391
Boston Scientific Corporation
$302
Merck Sharp & Dohme LLC
$287
E.R. Squibb & Sons, L.L.C.
$271
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$265
Amarin Pharma Inc.
$206
AstraZeneca Pharmaceuticals LP
$204
Esperion Therapeutics, Inc.
$188
Tactile Systems Technology Inc
$122
SANOFI-AVENTIS U.S. LLC
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
PFIZER INC.
$106
Medtronic Vascular, Inc.
$103
Inspire Medical Systems, Inc.
$99
ARBOR PHARMACEUTICALS, INC.
$97
Gilead Sciences, Inc.
$83
Medtronic, Inc.
$70
Kiniksa Pharmaceuticals, Ltd.
$51
Novo Nordisk Inc
$40
ABIOMED
$35
Regeneron Healthcare Solutions, Inc.
$35
BIOTRONIK INC.
$35
AltaThera Pharmaceuticals LLC
$29
CARDIVA MEDICAL, INC.
$27
Lundbeck LLC
$23
Impulse Dynamics (USA) Inc.
$23
Xeris Pharmaceuticals, Inc.
$22
Astellas Pharma US Inc
$22
Aziyo Biologics, Inc.
$20
Lexicon Pharmaceuticals, Inc.
$20
HeartFlow, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$19
Cardiovascular Systems Inc.
$18
Chiesi USA, Inc.
$16
AGEPHA Pharma FZ LLC
$16
Edwards Lifesciences Corporation
$14
Kowa Pharmaceuticals America, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Relypsa, Inc.
$12
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
AZURE XT DR MRI SURESCAN · Arcalyst · BRILINTA · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CONFIRM RX · Circulatory Support · Confirm Rx · Connectivity and Remote care · Corlanor · ECM · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FFRct · Flexitouch Plus · GVOKE PFS · HeartMate 3 Left Ventricular Assist Device · INSPIRE · Impella · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LODOCO · LifeVest · Livalo · MICRA · MULTAQ · Merlin Connectivity and Remote · Micra · NEXLETOL · NORTHERA · Optimizer Smart System · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · REVEAL LINQ · Repatha · Reveal LINQ · Rybelsus · SAPIEN 3 Ultra RESILIA · SEEQ · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $90 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
382
Per 100K population
8.0
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Baig is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 11% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Baig experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Baig performed 905 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baig receive payments from pharmaceutical companies?
Yes. Dr. Baig received a total of $5,399 from 42 companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baig's costs compare to other cardiologists in Houston?
Dr. Baig's average Medicare payment per service is $171. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baig) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Houston
Browse cardiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology